In a recent prospective multicenter study, involving 894 patients with stable CAD, elevated levels of TNFSF14 were independently associated with adverse CV outcomes (composite of CV death, nonfatal MI, and stroke) [28]. The gene discussed is TNFSF14; the disease is stroke disorder.